Report Detail

Request for Sample of this report

Medical Devices & Consumables Global In Vitro Testing for Infectious Diseases Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4682217
    • |
  • 27 February, 2026
    • |
  • Global
    • |
  • 143 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global In Vitro Testing for Infectious Diseases market size was valued at US$ 34380 million in 2025 and is forecast to a readjusted size of US$ 55770 million by 2032 with a CAGR of 7.2% during review period.
In vitro diagnostic (IVD) testing for infectious diseases involves laboratory-based analysis of biological samples, such as blood, urine, or swabs, to detect the presence of infectious agents or markers associated with infections. These tests play a crucial role in the diagnosis, monitoring, and management of infectious diseases.
The In Vitro Testing for Infectious Diseases market is driven by the global demand for rapid and accurate diagnostic solutions, particularly in the context of infectious diseases. In vitro diagnostic devices, encompassing molecular assays, immunoassays, and nucleic acid-based tests, play a pivotal role in the early detection and management of infectious pathogens. The ongoing threat of pandemics, such as the COVID-19 pandemic, has accelerated the need for advanced testing technologies. Additionally, the increasing prevalence of infectious diseases worldwide, coupled with initiatives to control their spread, fuels the market"s growth. Technological innovations, including point-of-care testing, contribute to the market"s dynamism, addressing the urgent need for timely and reliable infectious disease diagnostics.
This report is a detailed and comprehensive analysis for global In Vitro Testing for Infectious Diseases market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global In Vitro Testing for Infectious Diseases market size and forecasts, in consumption value ($ Million), 2021-2032
Global In Vitro Testing for Infectious Diseases market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global In Vitro Testing for Infectious Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global In Vitro Testing for Infectious Diseases market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for In Vitro Testing for Infectious Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global In Vitro Testing for Infectious Diseases market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, KHB, Daan Gene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
In Vitro Testing for Infectious Diseases market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Consumables
Equipment
Market segment by Application
Hepatitis
Pneumonia
Sexually Transmitted Diseases
Other
Market segment by players, this report covers
Roche
Siemens
Abbott
Danaher
Thermo Fisher
BioMerieux
Bio-Rad
BD
KHB
Daan Gene
Leadman
Zhongsheng
Bsbe
Maccura
Hitachi
Canon
Sysmex
Auto Bio
Mindray
Bgi
Wondfo
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe In Vitro Testing for Infectious Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In Vitro Testing for Infectious Diseases, with revenue, gross margin, and global market share of In Vitro Testing for Infectious Diseases from 2021 to 2026.
Chapter 3, the In Vitro Testing for Infectious Diseases competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and In Vitro Testing for Infectious Diseases market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of In Vitro Testing for Infectious Diseases.
Chapter 13, to describe In Vitro Testing for Infectious Diseases research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of In Vitro Testing for Infectious Diseases by Type
    • 1.3.1 Overview: Global In Vitro Testing for Infectious Diseases Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global In Vitro Testing for Infectious Diseases Consumption Value Market Share by Type in 2025
    • 1.3.3 Consumables
    • 1.3.4 Equipment
  • 1.4 Global In Vitro Testing for Infectious Diseases Market by Application
    • 1.4.1 Overview: Global In Vitro Testing for Infectious Diseases Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hepatitis
    • 1.4.3 Pneumonia
    • 1.4.4 Sexually Transmitted Diseases
    • 1.4.5 Other
  • 1.5 Global In Vitro Testing for Infectious Diseases Market Size & Forecast
  • 1.6 Global In Vitro Testing for Infectious Diseases Market Size and Forecast by Region
    • 1.6.1 Global In Vitro Testing for Infectious Diseases Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global In Vitro Testing for Infectious Diseases Market Size by Region, (2021-2032)
    • 1.6.3 North America In Vitro Testing for Infectious Diseases Market Size and Prospect (2021-2032)
    • 1.6.4 Europe In Vitro Testing for Infectious Diseases Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific In Vitro Testing for Infectious Diseases Market Size and Prospect (2021-2032)
    • 1.6.6 South America In Vitro Testing for Infectious Diseases Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa In Vitro Testing for Infectious Diseases Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.1.4 Roche In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Siemens
    • 2.2.1 Siemens Details
    • 2.2.2 Siemens Major Business
    • 2.2.3 Siemens In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.2.4 Siemens In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Siemens Recent Developments and Future Plans
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.3.4 Abbott In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abbott Recent Developments and Future Plans
  • 2.4 Danaher
    • 2.4.1 Danaher Details
    • 2.4.2 Danaher Major Business
    • 2.4.3 Danaher In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.4.4 Danaher In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Danaher Recent Developments and Future Plans
  • 2.5 Thermo Fisher
    • 2.5.1 Thermo Fisher Details
    • 2.5.2 Thermo Fisher Major Business
    • 2.5.3 Thermo Fisher In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.5.4 Thermo Fisher In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Thermo Fisher Recent Developments and Future Plans
  • 2.6 BioMerieux
    • 2.6.1 BioMerieux Details
    • 2.6.2 BioMerieux Major Business
    • 2.6.3 BioMerieux In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.6.4 BioMerieux In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BioMerieux Recent Developments and Future Plans
  • 2.7 Bio-Rad
    • 2.7.1 Bio-Rad Details
    • 2.7.2 Bio-Rad Major Business
    • 2.7.3 Bio-Rad In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.7.4 Bio-Rad In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bio-Rad Recent Developments and Future Plans
  • 2.8 BD
    • 2.8.1 BD Details
    • 2.8.2 BD Major Business
    • 2.8.3 BD In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.8.4 BD In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BD Recent Developments and Future Plans
  • 2.9 KHB
    • 2.9.1 KHB Details
    • 2.9.2 KHB Major Business
    • 2.9.3 KHB In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.9.4 KHB In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 KHB Recent Developments and Future Plans
  • 2.10 Daan Gene
    • 2.10.1 Daan Gene Details
    • 2.10.2 Daan Gene Major Business
    • 2.10.3 Daan Gene In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.10.4 Daan Gene In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Daan Gene Recent Developments and Future Plans
  • 2.11 Leadman
    • 2.11.1 Leadman Details
    • 2.11.2 Leadman Major Business
    • 2.11.3 Leadman In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.11.4 Leadman In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Leadman Recent Developments and Future Plans
  • 2.12 Zhongsheng
    • 2.12.1 Zhongsheng Details
    • 2.12.2 Zhongsheng Major Business
    • 2.12.3 Zhongsheng In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.12.4 Zhongsheng In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zhongsheng Recent Developments and Future Plans
  • 2.13 Bsbe
    • 2.13.1 Bsbe Details
    • 2.13.2 Bsbe Major Business
    • 2.13.3 Bsbe In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.13.4 Bsbe In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Bsbe Recent Developments and Future Plans
  • 2.14 Maccura
    • 2.14.1 Maccura Details
    • 2.14.2 Maccura Major Business
    • 2.14.3 Maccura In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.14.4 Maccura In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Maccura Recent Developments and Future Plans
  • 2.15 Hitachi
    • 2.15.1 Hitachi Details
    • 2.15.2 Hitachi Major Business
    • 2.15.3 Hitachi In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.15.4 Hitachi In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Hitachi Recent Developments and Future Plans
  • 2.16 Canon
    • 2.16.1 Canon Details
    • 2.16.2 Canon Major Business
    • 2.16.3 Canon In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.16.4 Canon In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Canon Recent Developments and Future Plans
  • 2.17 Sysmex
    • 2.17.1 Sysmex Details
    • 2.17.2 Sysmex Major Business
    • 2.17.3 Sysmex In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.17.4 Sysmex In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Sysmex Recent Developments and Future Plans
  • 2.18 Auto Bio
    • 2.18.1 Auto Bio Details
    • 2.18.2 Auto Bio Major Business
    • 2.18.3 Auto Bio In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.18.4 Auto Bio In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Auto Bio Recent Developments and Future Plans
  • 2.19 Mindray
    • 2.19.1 Mindray Details
    • 2.19.2 Mindray Major Business
    • 2.19.3 Mindray In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.19.4 Mindray In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Mindray Recent Developments and Future Plans
  • 2.20 Bgi
    • 2.20.1 Bgi Details
    • 2.20.2 Bgi Major Business
    • 2.20.3 Bgi In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.20.4 Bgi In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Bgi Recent Developments and Future Plans
  • 2.21 Wondfo
    • 2.21.1 Wondfo Details
    • 2.21.2 Wondfo Major Business
    • 2.21.3 Wondfo In Vitro Testing for Infectious Diseases Product and Solutions
    • 2.21.4 Wondfo In Vitro Testing for Infectious Diseases Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Wondfo Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global In Vitro Testing for Infectious Diseases Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of In Vitro Testing for Infectious Diseases by Company Revenue
    • 3.2.2 Top 3 In Vitro Testing for Infectious Diseases Players Market Share in 2025
    • 3.2.3 Top 6 In Vitro Testing for Infectious Diseases Players Market Share in 2025
  • 3.3 In Vitro Testing for Infectious Diseases Market: Overall Company Footprint Analysis
    • 3.3.1 In Vitro Testing for Infectious Diseases Market: Region Footprint
    • 3.3.2 In Vitro Testing for Infectious Diseases Market: Company Product Type Footprint
    • 3.3.3 In Vitro Testing for Infectious Diseases Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global In Vitro Testing for Infectious Diseases Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global In Vitro Testing for Infectious Diseases Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global In Vitro Testing for Infectious Diseases Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global In Vitro Testing for Infectious Diseases Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America In Vitro Testing for Infectious Diseases Consumption Value by Type (2021-2032)
  • 6.2 North America In Vitro Testing for Infectious Diseases Market Size by Application (2021-2032)
  • 6.3 North America In Vitro Testing for Infectious Diseases Market Size by Country
    • 6.3.1 North America In Vitro Testing for Infectious Diseases Consumption Value by Country (2021-2032)
    • 6.3.2 United States In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 6.3.3 Canada In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe In Vitro Testing for Infectious Diseases Consumption Value by Type (2021-2032)
  • 7.2 Europe In Vitro Testing for Infectious Diseases Consumption Value by Application (2021-2032)
  • 7.3 Europe In Vitro Testing for Infectious Diseases Market Size by Country
    • 7.3.1 Europe In Vitro Testing for Infectious Diseases Consumption Value by Country (2021-2032)
    • 7.3.2 Germany In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 7.3.3 France In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 7.3.5 Russia In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 7.3.6 Italy In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific In Vitro Testing for Infectious Diseases Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific In Vitro Testing for Infectious Diseases Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific In Vitro Testing for Infectious Diseases Market Size by Region
    • 8.3.1 Asia-Pacific In Vitro Testing for Infectious Diseases Consumption Value by Region (2021-2032)
    • 8.3.2 China In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 8.3.3 Japan In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 8.3.5 India In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 8.3.7 Australia In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America In Vitro Testing for Infectious Diseases Consumption Value by Type (2021-2032)
  • 9.2 South America In Vitro Testing for Infectious Diseases Consumption Value by Application (2021-2032)
  • 9.3 South America In Vitro Testing for Infectious Diseases Market Size by Country
    • 9.3.1 South America In Vitro Testing for Infectious Diseases Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa In Vitro Testing for Infectious Diseases Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa In Vitro Testing for Infectious Diseases Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa In Vitro Testing for Infectious Diseases Market Size by Country
    • 10.3.1 Middle East & Africa In Vitro Testing for Infectious Diseases Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)
    • 10.3.4 UAE In Vitro Testing for Infectious Diseases Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 In Vitro Testing for Infectious Diseases Market Drivers
  • 11.2 In Vitro Testing for Infectious Diseases Market Restraints
  • 11.3 In Vitro Testing for Infectious Diseases Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 In Vitro Testing for Infectious Diseases Industry Chain
  • 12.2 In Vitro Testing for Infectious Diseases Upstream Analysis
  • 12.3 In Vitro Testing for Infectious Diseases Midstream Analysis
  • 12.4 In Vitro Testing for Infectious Diseases Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on In Vitro Testing for Infectious Diseases. Industry analysis & Market Report on In Vitro Testing for Infectious Diseases is a syndicated market report, published as Global In Vitro Testing for Infectious Diseases Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of In Vitro Testing for Infectious Diseases market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo